Skip to content

Pharma.Tips

Unlocking Pharma's Secrets: Your Ultimate Guide to Pharmaceutical Success!

Tips for: Solid Oral Dosage Forms

Difficulty in Encapsulating Oils with High Peroxide Content

Posted on May 18, 2025 By Admin

Encapsulating oils in soft gelatin capsules is a common practice for delivering lipophilic active pharmaceutical ingredients (APIs) in a convenient oral dosage form. However, oils with high peroxide content present a unique challenge. Peroxides, which form during the oxidation of oils, are unstable and can cause degradation of both the API and the capsule itself. The presence of peroxides in oils can lead to reduced efficacy of the drug, potential side effects, and compromised product stability. Therefore, managing peroxide content in oils used for encapsulation is crucial for ensuring the safety and effectiveness of soft gelatin capsules.
Click to read the full article.

Capsules (Hard & Soft Gelatin)

Preventing Picking in Immediate Release Tablets During Compression

Posted on May 18, 2025 By Admin

Picking is a common issue that can occur during the compression stage of immediate release tablet manufacturing. It refers to the phenomenon where portions of the tablet surface stick to the punch faces or die cavity, causing material to be removed from the tablet and potentially leading to defects such as rough surfaces, weight variability, or inconsistent content distribution. Picking can result in rejected batches, increased material waste, and delays in production. Ensuring that tablets are formed with smooth, intact surfaces is crucial for both product quality and compliance with regulatory standards.
Click to read the full article.

Tablets

Problems with Achieving the Required Viscosity for Soft Gelatin Fill Material

Posted on May 18, 2025 By Admin

Achieving the required viscosity for soft gelatin fill material is a critical step in the development of soft gelatin capsules. The viscosity of the fill material impacts the encapsulation process, including the ease with which the material can be filled into the capsule, as well as the stability, flowability, and uniformity of the final product. Inadequate viscosity can lead to problems such as poor capsule sealing, uneven fill, or inconsistent dosing, all of which can affect the quality of the product. On the other hand, excessive viscosity can cause difficulties in handling and processing, and may lead to clogging or operational issues during capsule filling.
Click to read the full article.

Capsules (Hard & Soft Gelatin)

Ensuring Uniformity in API Distribution Across Tablet Layers

Posted on May 17, 2025 By Admin

In pharmaceutical tablet manufacturing, ensuring uniformity in the distribution of the active pharmaceutical ingredient (API) across tablet layers is critical for product efficacy, consistency, and regulatory compliance. This is especially important in multi-layer tablets, where each layer may contain a different combination of APIs or excipients. Inconsistent API distribution can lead to dose variability, compromised drug release profiles, and potential therapeutic failure. This article explores the challenges of achieving uniform API distribution in tablet layers and offers practical solutions to improve consistency during tablet manufacturing.
Click to read the full article.

Tablets

Incompatibility of High-Shear Granulation Processes with Capsule Formulations

Posted on May 17, 2025 By Admin

High-shear granulation is commonly used in the pharmaceutical industry for the preparation of granules that are later compressed into tablets or filled into capsules. However, this process can be incompatible with certain capsule formulations, particularly when dealing with APIs that are sensitive to shear forces or those requiring specific formulation conditions. The shear forces applied during granulation can alter the particle size, morphology, and solubility of the drug or its excipients, leading to challenges in ensuring uniformity, stability, and bioavailability in capsule formulations.
Click to read the full article.

Capsules (Hard & Soft Gelatin)

Addressing Granule Size Variability in Wet Granulation Processes

Posted on May 17, 2025 By Admin

Granulation is a critical step in tablet formulation, particularly in the production of tablets with consistent drug content and controlled release profiles. The wet granulation process involves the use of a liquid binder to agglomerate powder particles into granules, which are then dried and sieved to achieve the desired particle size. Granule size plays a significant role in tablet compressibility, dissolution, and uniformity. However, variability in granule size during wet granulation can lead to several production challenges, such as inconsistent tablet hardness, weight variation, and drug release profiles.
Click to read the full article.

Tablets

Issues with Developing Stable Dispersions for Soft Gelatin Capsules

Posted on May 17, 2025 By Admin

Developing stable dispersions for soft gelatin capsules can be challenging, particularly when dealing with poorly soluble active pharmaceutical ingredients (APIs) or those that are sensitive to environmental factors such as temperature, pH, or light. Dispersions, which involve the uniform distribution of the API within a liquid or semi-solid medium, are critical for ensuring the efficacy and bioavailability of the drug. However, formulating these dispersions into soft gelatin capsules requires overcoming issues like phase separation, viscosity instability, and poor API solubility, all of which can impact the performance of the final product.
Click to read the full article.

Capsules (Hard & Soft Gelatin)

Managing Blend Segregation in Free-Flowing Powders

Posted on May 17, 2025 By Admin

Blend segregation is a common challenge in the pharmaceutical manufacturing process, particularly when dealing with free-flowing powders. It occurs when the components of a powder blend—such as active pharmaceutical ingredients (APIs) and excipients—separate due to differences in particle size, density, or flow properties. Segregation can lead to issues like inconsistent content uniformity, poor tablet compression, and ultimately, variability in drug release and therapeutic effectiveness. These problems are especially prevalent in low-dose formulations or when blending large quantities of powder for batch production.
Click to read the full article.

Tablets

Reducing Rejection Rates Due to Cosmetic Defects in Coated Tablets

Posted on May 16, 2025 By Admin

Cosmetic defects in coated tablets, such as discoloration, streaks, uneven coating, or chips, are a significant issue in the pharmaceutical industry. These defects, while not affecting the efficacy or safety of the product, can lead to high rejection rates during quality control inspections, thereby increasing production costs and causing delays in packaging and distribution. Cosmetic defects can also affect the product’s marketability and consumer perception, especially for over-the-counter (OTC) products or those aimed at pediatric and geriatric populations.
Click to read the full article.

Tablets

Difficulty in Masking the Unpleasant Odor of Certain APIs

Posted on May 16, 2025 By Admin

The unpleasant odor of certain active pharmaceutical ingredients (APIs) can be a major challenge in drug formulation, especially when developing oral dosage forms such as capsules and tablets. APIs with strong or bitter smells, such as those used in antibiotics, vitamins, or certain hormonal treatments, can make it difficult to formulate palatable and acceptable drug products. This is particularly problematic in pediatric and geriatric populations, where the taste or smell of medication can lead to poor patient compliance. Masking the odor of APIs without compromising their therapeutic efficacy or the stability of the formulation requires careful selection of excipients and formulation strategies.
Click to read the full article.

Capsules (Hard & Soft Gelatin)

Troubleshooting Granulation Issues in Low-Dose API Formulations

Posted on May 16, 2025 By Admin

Granulation is a key step in tablet manufacturing that involves the formation of granules from powder particles. This process helps improve the flowability, compressibility, and uniformity of powders. However, granulating low-dose active pharmaceutical ingredients (APIs) presents unique challenges due to the small quantity of the API relative to the excipients. Low-dose APIs often require precise handling to ensure consistent distribution throughout the formulation, which is crucial for achieving the correct therapeutic effect. Issues such as poor granule size distribution, agglomeration, or inadequate content uniformity can significantly affect the final product’s quality and performance.
Click to read the full article.

Tablets

Formulation Development Challenges for Pediatric Capsule Dosage Forms

Posted on May 16, 2025 By Admin

Pediatric patients present unique challenges in pharmaceutical formulation, particularly when it comes to capsule dosage forms. Children often have different pharmacokinetic profiles, swallowing abilities, and taste preferences compared to adults, making it difficult to design effective and acceptable dosage forms. Hard gelatin capsules and soft gelatin capsules, which are commonly used for adult formulations, may not be suitable for pediatric use due to size, taste, and ease of administration concerns. Moreover, the need for accurate dosing, safety, and palatability complicates the development process for pediatric capsules.
Click to read the full article.

Capsules (Hard & Soft Gelatin)

Posts pagination

Previous 1 … 7 8 9 … 89 Next
  • Aerosol Formulations
  • Capsules (Hard & Soft Gelatin)
  • Drug Discovery
  • External Preparations
  • GLP Guidelines
  • GMP Guidelines
  • Medical Devices
  • Parenteral Drug Manufacturing
  • Pharma Quality Control
  • Pharma Research
  • Schedule M
  • Solid Dosage form
  • Solid Oral Dosage Forms
  • Tablets
  • Tablets

Copyright © 2025 Pharma.Tips.

Powered by PressBook WordPress theme